We are yery pleased that The Economist has published this article on PFS.
Thanks to all those who spoke to John - the author - to help him put this together.
It’s very encouraging to see an appropriate recognition of the breadth and severity of symptoms that almost always goes under-reported. It’s also great to see coverage that goes into the lack of predictive factors and how easy the drug is to access.
To treat the issue with respect and legitimacy in such a large, respected publication is pleasing.